SCHEMBL25933629

SCHEMBL25933629

CSc1ccc(Cc2ccccc2)c(N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.46
SLC6A4 P31645 3/20 0.46
SLC6A3 Q01959 2/20 0.46
TBXA2R P21731 1/20 0.41
PTGER3 P43115 1/20 0.41
PTGER2 P43116 1/20 0.41
PTGDR Q13258 1/20 0.41
BCL2 P10415 1/20 0.40
BCL2L1 Q07817 1/20 0.40
ALOX5 P09917 1/20 0.40
HTR2A P28223 1/20 0.38
KIF11 P52732 1/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.38
CALM1 P0DP23 1/20 0.37
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL810597 0.77 HDAC6 (0.47) SLC6A2SLC6A4SLC6A3BCL2BCL2L1
SCHEMBL1514183 0.76 HTR2A (0.48) BCL2BCL2L1ALOX5HTR2ACYP3A4
SCHEMBL18774026 0.75 SLC6A4 (0.49) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL27946 0.75 SLC6A4 (0.45) SLC6A2SLC6A4SLC6A3TBXA2RPTGER3
SCHEMBL25933630 0.73 ALDH1A1 (0.43) SLC6A2SLC6A4SLC6A3TBXA2RPTGER3
SCHEMBL27613417 0.73 SLC6A4 (0.58) SLC6A2SLC6A4SLC6A3TBXA2RPTGER3
SCHEMBL9656059 0.73 CYP3A4 (0.58) BCL2BCL2L1ALOX5HTR2AMEN1
SCHEMBL9851008 0.73 ALOX5 (0.67) BCL2BCL2L1ALOX5MEN1CYP3A4
SCHEMBL14254190 0.73 ALOX5 (0.47) SLC6A2SLC6A4BCL2BCL2L1ALOX5
SCHEMBL6159185 0.72 LTA4H (0.56) MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242502-A1 THIOBENZOPYRANS AND THEIR USE IN PREPARATION OF DRUGS FOR TREATMENT OF RHEUMATOID ARTHRITIS HC Synthetic Pharmaceutical Co., Ltd. (CN) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242502-A1 THIOBENZOPYRANS AND THEIR USE IN PREPARATION OF DRUGS FOR TREATMENT OF RHEUMATOID ARTHRITIS TST, SSB, HK1 SLC6A2 2959/4885SLC6A4 1959/4885SLC6A3 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.